Tor Biering-Sørensen talks with Aaysha Cader about the results of the DANFLU-1 trial which were presented during ESC Congress 2022 in Barcelona. In fact, elderly adults who received a high-dose quadrivalent influenza vaccine compared with a standard dose saw significantly reduced risk of death and hospitalization...

Mirvat Alasnag interviews Luigi Biasco, first author of the MitraSwiss Registry which was presented at the ESC Congress 2022 in Barcelona. Together, they discuss the enrolled population, the inclusion criteria, the design and outcomes of MitraSwiss, its comparison with other European registries and the restoration of...

In this conversation between Philipp Lurz and Felix Kreidel, recorded for EuroPCR 2022, learn more about the bRIGHT study and the latest outcomes released, and further understand TriClip therapy real-world outcomes applicability in daily practice.

View more videos and course resources here!

Watch this discussion between Jeffrey Jump and Jochen Reinöhl for EuroPCR 2022 to understand the importance of clinical data in bringing medical innovations to patients in need, the challenges and barriers in today’s landscape, and how the industry is overcoming these hurdles.

View more videos and course...

The prevalence of valvular heart disease increases with advanced age and unfortunately, in many patients, it’s underdiagnosed, especially aortic regurgitation. In this presentation recorded for PCR London Valves 2022, Tanja Rudolph raises the question: are we ready for TAVR in aortic regurgitation?

View more videos and course...

Follow this dialogue between Bernard Prendergast, Christopher Meduri and João Cavalcante where they reflect on the journey in relation to transcatheter aortic valve implantation over the last 20 years and advances that can take us to a very bright and optimistic future - recorded for PCR...

Join this discussion which was recorded in the PCR Live studio at PCR London Valves 2022, where Volker Rudolph and Azeem Latib, hosted by Philipp Lurz, talk about some new data and late trials in the field of transcatheter tricuspid valve therapies.

View more videos and course...

Watch this EuroPCR 2022 recording by Yoshinobu Onuma, Joanna Wykrzykowska, and Victor Alfonso Jimenez to understand why monotherapy following STEMI can be beneficial for patients, and why aspirin should be eliminated from post-PCI care, and to learn about the ASET SUPREME study.

View more videos and course...

Lars Søndergaard, Won-Keun Kim, and Christophe Saint Etienne came together for EuroPCR 2022 to share their experience of implanters achieving single-digit permanent pacemaker implantation: learn about the latest technique and new product features to reduce permanent pacemaker implantation.

View more videos and course resources here!

Mirvat Alasnag provides her take on the outcomes of small annuli sub-study from the FRANCE-TAVI Registry which included 1,195 patients. This trial was presented by Walid Ben-Ali at TCT 2022.

Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.

It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Jonathan Curio provides his take on the PROTECTED TAVR study which was presented by Samir R. Kapadia at TCT 2022. The aim was to evaluate whether TAVR with cerebral embolic protection would reduce the rate of clinical stroke in transfemoral TAVR.

Alessandro Sticchi and Luigi Biasco provide their take on the 1-year results of the CLASP TR study which were presented by Dr Adan Greenbaum, co-director of the Emory Structural Heart and Valve Center (Atlanta, GA) during the 2022 American College of Cardiology annual Congress held in Washington D.C.

Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.

The EuroIntervention Journal is pleased to announce its 2021 Impact Factor: 7.728 (2021 Journal Citation Reports® Science Edition (Clarivate Analytics, 2022)

With this result, we confirm last year's progression and we are proud to be listed 2nd amongst interventional cardiology journals. 

This single-arm, double-blinded, core-laboratory adjudicated, prospective trial, conducted across four European centers between August 2019 and April 2022, investigates whether CCTA and FFR-CT are able to exclude hemodynamically significant coronary stenoses in patients with high-risk NSTE-ACS.

Mirvat Alasnag interviews David Meier about his TCT2022 poster presentation which was simultaneously published in the EuroIntervention Journal: Timing of Bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity. EuroIntervention, Meier et al. DOI: 10.4244/EIJ-D-22-00644

Results show that bioprosthetic valve fracture performed after VIV appears to offer...

Watch Luis Ortega Paz's interview with David Berg as part of the ESC 2022 Congress coverage, and find out more about the COVID-PACT trial, which aims to study antithrombotic strategies in critically ill COVID-19 patients. Learn more about the study design (population, primary endpoint, safety criteria...)...

Aaysha Cader interviews Rania Hammami, Principal Investigator of the RIVARAD trial. They discuss the design and results of the trial which was presented during #TCT2022.

RIVARAD is the first multicentric randomized trial with 30-day RAOs as the primary endpoint, which proved the efficacy of short-term use of...

Watch this interview of Tom Johnson by Jan McCloud recorded for EuroPCR 2022 to understand how MLD MAX workflow improves decision-making, efficiency, and product utilisation, and how it can lower radiation exposure while keeping the contrast use constant when compared to angiography-guided PCI.

View more videos and course...